ConductScience.org, home

Paper761333

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.

Packer M and 3 others. Circulation, 1979. Cited by 246 papers, by iCite.

Cite this record

ConductScience Library. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Papers, record 761333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/761333

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
PubMed
Journal
Circulation
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
246
iCite
Relative citation ratio, by iCite
10.7
iCite
Revised in PubMed
2019-06-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Packer MM
2Meller JJ
3Gorlin RR
4Herman MVM V

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
HemodynamicsMajor topic
PrazosinMajor topic
QuinazolinesMajor topic
TachyphylaxisMajor topic
Aged
Chronic Disease
Dose-Response Relationship, Drug
Humans
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 246 citations.

PMIDTitleJournalYearIn PapersSource
8575562Influence of repeated prazosin administration on cardiovascular responses in rats and rabbits.Experientia1996https://conductscience.org/library/papers/8575562PubMed
7459177Acute and chronic haemodynamic effects of prazosin in left ventricular failure.Br Heart J1981https://conductscience.org/library/papers/7459177PubMed
7317235Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.Br Heart J1981https://conductscience.org/library/papers/7317235PubMed
7287364Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure.Ir J Med Sci1981https://conductscience.org/library/papers/7287364PubMed
7225252Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.Br Heart J1981https://conductscience.org/library/papers/7225252PubMed
7066169The addition of prazosin to standard triple therapy in the treatment of severe hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7066169PubMed
6785251Afterload reduction in the therapy of heart failure.Ir J Med Sci1980https://conductscience.org/library/papers/6785251PubMed
6753904Long-term treatment of congestive heart failure with captopril.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6753904PubMed
6753896Acute and chronic effects of captopril therapy in patients with refractory heart failure.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6753896PubMed
6466518Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.Br Heart J1984https://conductscience.org/library/papers/6466518PubMed
6349967Vasodilator therapy in chronic congestive heart failure.Drugs1983https://conductscience.org/library/papers/6349967PubMed
6336940Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Br Heart J1983https://conductscience.org/library/papers/6336940PubMed
6303744Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.Drugs1983https://conductscience.org/library/papers/6303744PubMed
6137226Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.Br Heart J1983https://conductscience.org/library/papers/6137226PubMed
6125370Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.Drugs1982https://conductscience.org/library/papers/6125370PubMed
61196203H-WB 4101 binding in the rat vas deferens. Effects of chronic treatments with desipramine and prazosin.Naunyn Schmiedebergs Arch Pharmacol1981https://conductscience.org/library/papers/6119620PubMed
6112039Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6112039PubMed
4015915Milrinone in heart failure. Effects on exercise haemodynamics during short term treatment.Br Heart J1985https://conductscience.org/library/papers/4015915PubMed
3743613The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3743613PubMed
3552590The role of vasodilator therapy in the treatment of severe chronic heart failure.Drugs1986https://conductscience.org/library/papers/3552590PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/761333

GET https://conductscience.org/api/papers/v1/761333/cited_by?page=2